Our in vitro data provide an appropriate explanation by demonstrating that Twist1-overexpressing AML cells are more vulnerable to the cytotoxicity of phase-specific cytarabine through suppression of cell cycle regulator p16. This evidence concerns the gene TWIST1 and acute myeloid leukemia.